This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Algeta To Host Capital Markets Days

OSLO, Norway, Nov. 18, 2013 (GLOBE NEWSWIRE) --

Intended for US media only

Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, will host Capital Markets
Days this week in Oslo, London and New York.

Event summaries and guest speaker details are provided below.

Oslo, 18 November 10:00am-2:00pm (CET)
KS-Agenda Møtesenter, Haakon VII's gate 9

  * Dr Dag Clement Johannessen, Consultant Oncologist, Department of Oncology,
    University Hospital of Oslo, Norway
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

London, 19 November 10:00am-2:00pm (GMT)
Holborn Bars 2(nd) Floor, 138-142 Holborn

  * Dr E. David Crawford, Professor of Surgery (Urology) & Radiation Oncology,
    Head Urologic Oncology, University of Colorado, Denver, USA
  * Dr Sten Nilsson, Professor of Oncology, Karolinska Institutet and University
    Hospital, Stockholm, Sweden

New York, 21 November 12.30pm-4:30pm (EDT)
Parker Meridien, 118 West 57(th) Street

  * Dr Dan George, Director, GU Oncology, Duke Cancer Institute, Duke University
    Medical Center, Durham, North Carolina, USA
  * Dr Neal D. Shore, Director, CPI, Carolina Urologic Research Center, Atlantic
    Urology Clinics, Myrtle Beach, South Carolina, USA

The  event in New  York will be  webcast via, where presentations
will also be made available.


For further information, please contact:

 Mike Booth                             +1 646 410 1884

 Communications & Corporate Affairs

 Media enquiries:

 Mark Swallow                           +44 207 638 9571

 Citigate Dewe Rogerson       

 Kari Watson                            +1 781 235 3060

 MacDougall Biomedical Communications

 Investor enquiries:

 Tricia Truehart                        +1 646 378 2953

 The Trout Group              

About Algeta

Algeta is a company focused on developing, manufacturing and marketing novel
targeted therapies for patients with cancer. The Company is headquartered in
Oslo, Norway, and has a US subsidiary, Algeta US, LLC, based in Cambridge, MA
performing commercial marketing operations in the US. Algeta is listed on the
Oslo Stock Exchange (Ticker: ALGETA). For more information please visit

Press release:


Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs